Search research articles
Contact Us
Filters
Showing results (131-140 of 162) with videos related to
Page
of 17
Sort By:
Nature
|
January 28, 2016
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques
Olivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Plos Pathogens
|
September 25, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection
Olivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
The Journal of Infectious Diseases
|
September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy
Jacob D Estes, Cavan Reilly, Charles M Trubey, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
Iscience
|
March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2008
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions
Rita B Effros, Courtney V Fletcher, Kelly Gebo, et al.
Nature Medicine
|
February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
Jeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 162) with videos related to
Sort By:
Page
of 17
Nature
|
January 28, 2016
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques
Olivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
Plos Pathogens
|
September 25, 2023
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection
Olivia E Harwood, Lea M Matschke, Ryan V Moriarty, et al.
The Journal of Infectious Diseases
|
September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy
Jacob D Estes, Cavan Reilly, Charles M Trubey, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
Iscience
|
March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2008
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions
Rita B Effros, Courtney V Fletcher, Kelly Gebo, et al.
Nature Medicine
|
February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
Jeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Page
of 17